Srikrishna Jayadev M

No ORCID on file · 1 paper in corpus
lab-animal 2021
·doi:10.21203/rs.3.rs-556331/v1

Abstract CDK4/6 inhibitors (Abemaciclib, Ab and Palbociclib, Pb) stop the G1-phase in cell-cycle being used to cure advanced stage of breast cancer (BC). Acquired resistance is a major challenge in BC therapy. The molecular signature of th…